Fortress Biotech (FBIO) Stock Highlights

1.57 | -1.26%

2024-11-21 06:13:45

Fortress Biotech Inc is a biopharmaceutical company. The firm is involved in the business of acquiring, developing, and commercializing pharmaceutical and biotechnology products. Its product portfolio encompasses Targadox, Exelderm, Ceracade, Luxamend, and Dermasorb. The business activities of the group are functioned through Dermatology Product Sales, and Pharmaceutical and Biotechnology Product Development. It derives the majority of its revenues from Dermatology segment. Its subsidiaries also operate in biotechnology, pharmaceutical, oncology, therapeutics sectors.

Statistics

Range Today

1.55 1.63

Volume Today 379.2K

Range 1 Year

1.36 4.43

Volume 1 Year 112.32M

Range 3 Year

1.24 46.8

Volume 3 Year 143.72M

Range 10 Year

1.24 91.5

Volume 10 Year 198.97M

Highlights

Market Capitalization 47.41M (micro)

Floating Shares 15.82M

Current Price 1.57

Price To Earnings -0.06

Price To Revenue 0.23

Price To Book 2.16

Earnings Per Share -27.57

Payout Ratio 0%

Performance

Latest -1.26%

1 Month -12.78%

3 Months -18.23%

6 Months -16.93%

1 Year -31.14%

3 Years -96.59%

5 Years -94.19%

10 Years -94.34%

Benchmarks

Market Capitalization

308 / 368

Gross Profits

0 / 278

Total Revenue

111 / 300

Total Rank

129 / 368

Free Cashflow

276 / 352

Performance 5 years

301 / 368

Obligatory risk notice

We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.